Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2022-03-01
2024-07-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aims of this study are, therefore, to: 1) establish whether larger individuals display higher rates of exogenous carbohydrate oxidation than smaller individuals; and 2) establish if such a difference can be explained by the higher absolute exercise intensity, and thus the energy demand of exercise. It is hypothesised that larger individuals will demonstrate higher exogenous carbohydrate oxidation rates than smaller individuals, and that this difference will be partly (but not completely) diminished when the absolute intensity of exercise is matched.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Responses to Manipulating Dietary Carbohydrate Content on Free-living Physical Activity Energy Expenditure
NCT03917810
Intermittent Carbohydrate Restriction in Cardiometabolic Health
NCT06684834
Effects of Low Fat Versus Low Carbohydrate Diets on Energy Metabolism
NCT03878108
Fatty Acid Metabolism and Insulin Sensitivity After Exercise in Obesity
NCT01451957
Exercise Substrate Utilisation and Endurance Performance Following Short-term Manipulation of Dietary Fat Intake
NCT02568592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
<70 kg body mass
Cyclists or triathletes with a body mass of less than 70 kg
Moderate-intensity (relative) exercise with glucose ingestion
120 minutes of cycling at 95% of lactate threshold ingesting 90 g/h of glucose
>70 kg body mass
Cyclists or triathletes with a body mass of less than 70 kg
Moderate-intensity (relative) exercise with glucose ingestion
120 minutes of cycling at 95% of lactate threshold ingesting 90 g/h of glucose
Moderate-intensity (absolute) exercise with glucose ingestion
120 minutes of cycling at a power matched to participant in the \<70 kg body mass group, ingesting 90 g/h of glucose
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Moderate-intensity (relative) exercise with glucose ingestion
120 minutes of cycling at 95% of lactate threshold ingesting 90 g/h of glucose
Moderate-intensity (absolute) exercise with glucose ingestion
120 minutes of cycling at a power matched to participant in the \<70 kg body mass group, ingesting 90 g/h of glucose
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* VO2max of between 40-75 mL/kg/min
* Fat-mass index (determined by dual energy x-ray absorptiometry) \< 5.5 kg·m-2
Exclusion Criteria
* People following a low-carbohydrate, high-fat diet
* Pregnant or lactating
* Diagnosed cardiovascular disease
* Possible symptoms of cardiovascular disease
* Diagnosis of diabetes of any type
* Hypercholesterolaemia (total cholesterol ≥ 6.2 mmol/L
* Hypertension (systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg)
* Current smoker
* Family history of coronary artery disease (first-degree relative \<60 years)
* Prevalence of vascular disease
* Autonomic neuropathy
* Kidney disease
* Diagnosed pulmonary disease (e.g. chronic obstructive pulmonary disease, asthma, interstitial lung disease or cystic fibrosis)
* Blood borne disease or infection
* Osteoporosis
* Osteoarthritis
* Blood clotting disorders
* Food intolerances/allergies (these may not specifically exclude you- please talk to the investigator)
* Sensitivity or allergy to anaesthetic
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Birmingham
OTHER
University of Bath
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Javier Gonzalez
Reader (Associate Professor) in Human Physiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department for Health, University of Bath
Bath, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6632
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.